|
 |
|
|||||||
|
|||||||||
DOI: 10.2337/dc06-2416
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Research |
Adipokines and risk of type 2 diabetes in older men
1Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Rowland Hill St, London NW3 2PF, UK
2British Heart Foundation Glasgow Cardiovascular Research University of Glasgow, Glasgow G31 2ER
3Division of Community Health Sciences, St George's, University of London, London SW17 ORE, UK
goya{at}pcps.ucl.ac.uk
ABSTRACT
Aim The aim was to assess the relationship between adipokines including interleukin 6 (IL-6), leptin and adiponectin with development of type 2 diabetes and assess the role of obesity and insulin resistance in these relationships.
Methods A prospective study of 3599 non-diabetic men aged 60-79 followed up for a mean period of 5 years during which there were 108 incident cases of type 2 diabetes.
Results Elevated IL-6 and leptin and low adiponectin were associated with increased risk of type 2 diabetes even after adjustment for BMI, lifestyle factors, pre-existing cardiovascular disease and systolic blood pressure. The relative risks (95% CI) (3rd versus 1st third) were 2.02 (1.14,3.58) for IL6, 1.91 (0.97,3.76) for leptin, and 0.40 (0.23,0.70) for adiponectin. Further adjustment for insulin resistance made minor differences to the IL-6 diabetes relationship [adjusted RR 2.1 (1.18,3.81), weakened the associations with adiponectin (adjusted RR 0.59 (0.33,1.04) and abolished the association between leptin and diabetes [adjusted RR 1.12 (0.55,2.26)]. The inverse relation between low adiponectin and diabetes was significantly stronger in men who were obese (waist circumference >102 or BMI > 30kg/m) [adjusted RR 0.30 (0.11,0.7)] relative to leaner men [adjusted RR 0.93 (0.44,1.55)] (test for interaction p=0.04).
Conclusion The association between leptin and incident diabetes is mediated by insulin resistance. By contrast the positive association between IL-6 and diabetes appeared to be independent of obesity and insulin resistance. Finally, the association between low adiponectin and increased risk of diabetes appears to be significantly stronger in obese men than leaner counterparts.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  G. R. Hajer, T. W. van Haeften, and F. L.J. Visseren Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur. Heart J., September 5, 2008; (2008) ehn387v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Heidemann, Q. Sun, R. M. van Dam, J. B. Meigs, C. Zhang, S. S. Tworoger, C. S. Mantzoros, and F. B. Hu Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women Ann Intern Med, September 2, 2008; 149(5): 307 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sattar and S. M. Nelson Adiponectin, Diabetes, and Coronary Heart Disease in Older Persons: Unraveling the Paradox J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3299 - 3301. [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koh, S. M. Park, and M. J. Quon Leptin and Cardiovascular Disease: Response to Therapeutic Interventions Circulation, June 24, 2008; 117(25): 3238 - 3249. [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, P. Watt, L. Cherry, S. Ebrahim, G. Davey Smith, and D. A. Lawlor High Molecular Weight Adiponectin Is Not Associated with Incident Coronary Heart Disease in Older Women: A Nested Prospective Case-Control Study J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1846 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Wannamethee, N. Sattar, A. Rumley, P. H. Whincup, L. Lennon, and G. D.O. Lowe Tissue Plasminogen Activator, von Willebrand Factor, and Risk of Type 2 Diabetes in Older Men Diabetes Care, May 1, 2008; 31(5): 995 - 1000. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |